Bio-Rad Laboratories | BIO - Aktuelle Verpflichtungen

Aktienkurs
287.84
Täglich Wechseln
6.42 2.28%
Monatlich
5.20%
Jährlich
18.77%
Q2 Prognose
281.68




Aktuelle Verpflichtungen Veränderung Datum
Abbott USD 16.5B 1.91B 2025-12
Agilent USD 2.23B 113M 2025-12
Becton, Dickinson and Co. USD 8.76B 448M 2025-12
Bio Techne USD 140.43M 4.12M 2025-12
Bio-Rad Laboratories USD 517M 5.3M 2025-12
Bruker USD 1.28B 11.1M 2025-12
Charles River Laboratories USD 1.12B 1.57M 2025-12
Danaher USD 7.46B 653M 2026-03
General Electric Aerospace USD 40.03B 1.05B 2026-03
Illumina USD 1.59B 377M 2025-12
IQVIA Holdings USD 8.34B 170M 2025-12
Laboratory Of America USD 2.82B 194.3M 2025-12
Merck USD 28.63B 2.59B 2025-09
Mettler Toledo International USD 1.2B 5.99M 2025-12
Myriad Genetics USD 133.8M 14.2M 2025-12
OraSure Technologies USD 39.8M 453K 2025-12
Pacific Biosciences Of California USD 72.83M 9.62M 2025-12
Quest Diagnostics USD 2.18B 101M 2026-03
Repligen USD 135.83M 4.69M 2025-12
Revvity USD 1.33B 108.5M 2025-12
Roche Holding CHF 28B 421M 2025-12
Siemens EUR 49.35B 2.09B 2025-12
Standard Biotools USD 108.31M 343K 2025-12
Thermo Fisher Scientific USD 14.62B 568M 2026-03
Tosoh JPY 340.28B 25.85B 2025-12
Waters USD 1.24B 11.8M 2025-12